Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 4.02 B4.04 B3.98 B4.08 B 16.11 B Research & development ———— — Operating income 919 M1 B522 M1.3 B 3.75 B Non-Operating Income, Total 26 M26 M200 M57 M 309 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 49 M42 M118 M47 M 256 M Unusual income/expense -23 M-16 M82 M10 M 53 M Pretax income 922 M999 M650 M1.33 B 3.9 B Equity in earnings ———— — Taxes 195 M207 M130 M260 M 792 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 727 M792 M520 M1.07 B 3.11 B Discontinued operations ———— — Net income 727 M792 M520 M1.07 B 3.11 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 727 M792 M520 M1.07 B 3.11 B Basic earnings per share (Basic EPS) 0.490.540.350.72 2.1 Diluted earnings per share (Diluted EPS) 0.490.530.350.73 2.1 Average basic shares outstanding 1.48 B1.48 B1.48 B1.48 B — Diluted shares outstanding 1.48 B1.48 B1.48 B1.48 B — EBITDA 1.11 B1.18 B707 M1.49 B 4.49 B EBIT 919 M1 B522 M1.3 B 3.75 B Cost of revenue 6.78 B7.38 B6.75 B5.58 B 26.49 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 190 M179 M185 M193 M 747 M